Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Non-Current Assets (2016 - 2025)

Adma Biologics' Non-Current Assets history spans 14 years, with the latest figure at $157.7 million for Q4 2025.

  • For Q4 2025, Non-Current Assets changed 0.29% year-over-year to $157.7 million; the TTM value through Dec 2025 reached $641.3 million, up 70.18%, while the annual FY2025 figure was $157.7 million, 0.29% changed from the prior year.
  • Non-Current Assets reached $157.7 million in Q4 2025 per ADMA's latest filing, down from $166.0 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $166.0 million in Q3 2025 to a low of $58.4 million in Q1 2021.
  • Average Non-Current Assets over 5 years is $93.4 million, with a median of $74.9 million recorded in 2023.
  • Peak YoY movement for Non-Current Assets: dropped 7.55% in 2023, then soared 129.25% in 2025.
  • A 5-year view of Non-Current Assets shows it stood at $67.5 million in 2021, then increased by 15.6% to $78.1 million in 2022, then dropped by 7.55% to $72.2 million in 2023, then soared by 117.92% to $157.3 million in 2024, then rose by 0.29% to $157.7 million in 2025.
  • Per Business Quant, the three most recent readings for ADMA's Non-Current Assets are $157.7 million (Q4 2025), $166.0 million (Q3 2025), and $158.8 million (Q2 2025).